SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.
SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Allows for Immediate 340B Enrollment in Texas Due to Hurricane; Hawaii Remains Eligible

Due to Hurricane Beryl, certain Texas providers can immediately enroll in the 340B program without waiting for the normal registration period.
Eligible providers in Texas can now immediately enroll in the 340B program without waiting for the normal quarterly registration period [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sen. Cassidy Claims 340B Hospitals Drive Medical Debt During Key Senate Committee Hearing

Sen. Bill Cassidy (R) said many major nonprofit hospitals are "not passing on savings from 340B" in a Senate committee hearing on medical debt.
Certain hospitals’ failure to pass 340B savings on to patients is a leading cause of medical debt, two Republican lawmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

CMS recently proposed a rule to fulfill its statutory obligation to exclude 340B claims from Medicare inflationary rebates.
The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Study Finds Oncology Markups at 340B Pediatric Hospitals; AHA Slams Study and Funder 

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.
The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Upcoming Federal Elections Will Significantly Impact 340B Legislative Agenda, Say 340B Hospital Lobbyist, Drug Industry Analyst

Tom O’Donnell, senior vice president of government relations at 340B Health, and Michael McCaughan, co-founder of Provision Policy, gave a July 10 address at the 340B Coalition summer conference.
The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Advocates March on Capitol Hill to ‘Defend 340B’ Amid D.C. Heat Wave

More than 60 advocates marched on Capitol Hill amid a heat wave in Washington, D.C. for the third annual "Defend 340B March" on July 10.
More than sixty 340B advocates braved an excessive heat warning in the nation’s capital yesterday afternoon for the third annual [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Hampshire Enacts Law to Bar PBMs, Payers from ‘Discriminating Against’ 340B Providers

New Hampshire Gov. Chris Sununu (R) signed a law prohibiting certain 340B-specific policies by PBMs and payers.
New Hampshire Gov. Chris Sununu (R) yesterday signed a law prohibiting payers and pharmacy benefit managers (PBMs) from “discriminating against [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Apotex to Issue Refunds to 340B Covered Entities 

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live